Migraine
For patient information, click here
Editor-In-Chief: Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Andrea Tamayo Soto [2] Teresa Stahl, M.D. [3] Rithish Nimmagadda,MBBS.[4]
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Migraine is a neurological disease best known for severe headaches that are its most salient symptom.[1][2][3]. Usually migraine causes episodes of severe or moderate headache (which is often one-sided and pulsating) lasting between several hours to three days, accompanied by gastrointestinal upsets, such as nausea and vomiting, and a heightened sensitivity to bright lights (photophobia) and noise (phonophobia). Approximately one third of people who experience migraine get a preceding aura.[4] Migraines’ secondary characteristics are inconsistent. Triggers precipitating a particular episode of migraine vary widely. The efficacy of the simplest treatment, applying warmth or coolness to the affected area of the head, varies between persons, sometimes worsening the migraine.[5] A particular migraine rescue drug may sometimes work and sometimes not work in the same patient. Some migraine types don’t have pain or may manifest symptoms in parts of the body other than the head. Available evidence suggests that migraine pain is one symptom of several to many disorders of the serotonergic control system, a dual hormone–neurotransmitter with numerous types of receptors. Two disorders — classic migraine with aura (MA, STG) and common migraine without aura (MO, STG) — have been shown to have a genetic factor.[6] Studies on twins show that genes have a 60 to 65% influence on the development of migraine[7][8]. Additional migraine types are suspected and could be proven to be genetic. Migraine understood as several or many disorders could explain the inconsistencies, especially if a single patient has more than one genetic type. However, still other migraine types might be functionally acquired due to hormone organ disease or injury. Three quarters of adult migraine patients are female, although pre-pubertal migraine affects approximately equal numbers of boys and girls. This reveals the strong correlation to hormonal cycling and hormonal-related causes or triggers. Hormonal migraine is a likely consequence of periodically falling hormone levels causing reduction in protein biosynthesis of metabolic components including intestinal tract serotonin.
Historical Perspective
The word migraine is French in origin and comes from the Greek hemicrania, as does the Old English term megrim. Literally, hemicrania means “half (the) head”.
Classification
Migraines can be divided in three different types: migraine without aura, typical migraine with aura and probable migraine without aura. Migraines are often underdiagnosed and misdiagnosed.[9][10] The diagnostic criteria for migraine include recurrent headache disorder manifesting in attacks that fulfill typical characteristics in a context of normal clinical examination that rules out other diagnoses. Migraine with aura is a recurrent disorder manifesting in attacks of reversible focal neurological symptoms that usually develop gradually over 5–20 minutes and last for less than 60 minutes.
Pathophysiology
Migraines are believed to be a neurovascular disorder[11][12] with evidence supporting its mechanisms starting within the brain and then spreading to the blood vessels.[13] Migraine begins by neuronal changes leading to the activation of the brainstem and diencephalic nuclei and subsequent dilatation of the large cranial and proximal intracranial vessels.[11] Some researchers feel neuronal mechanisms play a greater role,[14] while others feel blood vessels play the key role.[15] Others feel both are likely important.[16] High levels of the neurotransmitter serotonin, also known as 5-hydroxytryptamine, are believed to be involved.[13]
Triggers
A migraine trigger is any factor that, on exposure or withdrawal, leads to the development of an acute migraine headache. Triggers may be categorized as behavioral, environmental, infectious, dietary, chemical, or hormonal.In the medical literature, these factors are known as precipitants. Many people report that one or more dietary, physical, hormonal, emotional, or environmental factors precipitate their migraines. The most-often reported triggers include: pesticides (sprayed fruits/vegetables), perfumes or fragrances (30% of sufferers) stress, over-illumination or glare, alcohol, foods, too much or too little sleep, and weather. Some women experience migraines in conjunction with monthly menstrual cycles. Sometimes the migraine occurs with no apparent “cause”. The trigger theory supposes that exposure to various environmental factors precipitates, or triggers, individual migraine episodes. Migraine patients have long been advised to try to identify personal headache triggers by looking for associations between their headaches and various suspected trigger factors. Patients are urged to keep a “headache diary” in which to note what they eat and when they get a headache, to look for correlations, and to try to avoid headache by avoiding factors they identify as triggers. Typically this advice is accompanied by a list of trigger factors.
Differential Diagnosis
ther conditions that can cause similar symptoms to a migraine headache include temporal arteritis, cluster headaches, acute glaucoma, meningitis and subarachnoid hemorrhage.[17] Temporal arteritis typically occurs in people over 50 years old and presents with tenderness over the temple, cluster headaches presents with one-sided nose stuffiness, tears and severe pain around the orbits, acute glaucoma is associated with vision problems, meningitis with fevers, and subaracchnoid hemorrhage with a very fast onset.[17] Tension headaches typically occur on both sides, are not pounding, and are less disabling.[17]
Epidemiology and Demographics
Migraine is widespread in the population. The majority of migraine (as it is referred to commonly) is actually mixed Headache. In the U.S., 18% of women and 6% of men report having had at least one migraine episode in the previous year[18] According to reports, 10% of people have been diagnosed with migraine and 5% have migraine but have not been diagnosed, with seriousness varying from a rare annoyance to a life-threatening and/or daily experience.
Natural History, Complications and Prognosis
Migraine with aura is associated with increased risk of subsequent stroke, a risk further amplified among females, smokers, patients on OCP and patients suffering from frequent migraine episodes. Despite the elevated risk of stroke among patients with migraine associated with aura, the incidence of stroke in this category of patients remain low particularly in young adults. Patients with migraine not associated with aura are not at an increased risk of stroke compared to the general population.[19]
Diagnosis
History and Symptoms
The signs and symptoms of migraine vary among patients. Therefore, what a patient experiences before, during and after an attack cannot be defined exactly. The four phases of a migraine attack listed below are common but not necessarily experienced by all migraine sufferers. Additionally, the phases experienced and the symptoms experienced during them can vary from one migraine attack to another in the same patient: (1) the prodrome, which occurs hours or days before the headache, (2) the aura, which immediately precedes the headache, (3) the pain phase, also known as headache phase and (4) the postdrome phase.
Physical Examination
The majority of patients with headaches complaints have a normal physical and neurological examination. Signs suggestive of a serious cause of headache, such as systemic symptoms, focal neurological signs, seizures or impairment of the level of consciousness should be ruled out.
Laboratory Findings
Migraine is a clinical diagnosis that does not require any laboratory tests. Laboratory tests can be ordered to rule out any suspected coexistent metabolic problems or to determine the baseline status of the patient before initiation of migraine therapy. When the headache is suggestive of meningitis, lumbar puncture should be done and an appropriate management of meningitis should be initiated.
CT
Neuroimaging is not necessary in patients with a clinical diagnosis of migraine. Head images such CT and MRI might be needed to rule out other suspected possible causes of headache. It is suggested to order a CT scan without contrast among patients with an unusual headache.
MRI
MRI is indicated when there is suspicion of posterior fossa lesions and cerebrospinal fluid (CSF) leak. Magnetic resonance angiography (MRA) and magnetic resonance venography (MRV) are indicated in arterial or venous lesions.
Treatment
Medical Therapy
Conventional treatment focuses on three areas: trigger avoidance, symptomatic control, and preventive drugs. Migraine sufferers usually develop their own coping mechanisms for the pain of a migraine attack. Medical therapy can be divided into two treatment regimens: non-specific treatment such as non-steroidal anti-inflammatory drug and analgesics and specific treatment such as triptans and ergot derivatives.[20] Patients who experience migraines often find that the recommended treatments are not 100% effective at preventing migraines, and sometimes may not be effective at all.
Secondary Prevention
Following treatment of an acute migraine, it is important to consider preventive measures. Preventive measures include medications such as NSAIDs, amitryptilline, devalproex, valproic acid, propranolol, timolol and topiramate among others. If the preventive measure is not effective after two to three months, the dose of the medication should be adjusted. If no improvement is noted, another first line therapy or a combination of two first line therapies should be initiated.[21][22]
Cost-Effectiveness of Therapy
Treatments are typically expensive. Periodic or unpredictable disability can cause impoverishment due to patients’ inability to work enough or to hold a job at all.
References
- ↑ “NINDS Migraine Information Page”. National Institute of Neurological Disorders and Stroke, National Institutes of Health. Retrieved 2007-06-25.
- ↑ “Advances in Migraine Prophylaxis: Current State of the Art and Future Prospects” (PDF). National Headache Foundation (CME monograph). Retrieved 2007-06-25.
- ↑ “Migraine: diagnosis, management, and new treatment options, Gallagher RM, Cutrer FM, University of Medicine and Dentistry of New Jersey, School of Medicine, Stratford, USA”. The American Journal of Managed Care, PMID: 11859906. Retrieved 2007-06-25.
- ↑ “Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache, Jan 2007,British Association for the Study of Headache” (PDF). Retrieved 2007-06-25.
- ↑ The Essential Book of Herbal Medicine (also known as Out of the Earth) by Simon Y. Mills, Viking Arkana, 1994(1991). Mills is former president of the UK licensed medical herbalists association. Mills’ point is the traditional classification of migraines into “hot” and “cold” types, meaning that one’s migraine type is determined by whether one’s pain is reduced by hot/warm versus cold water.
- ↑ Ogilvie AD, Russell MB, Dhall P, et al. “Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura.” Cephalalgia. 1998 Jan;18(1):23-6. PMID 9601620
- ↑ Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB (1999). “The inheritance of migraine with aura estimated by means of structural equation modelling”. Journal of Medical Genetics. 36 (3): 225–7. PMC 1734315. PMID 10204850. Retrieved 2012-08-30. Unknown parameter
|month=ignored (help) - ↑ Gervil M, Ulrich V, Kaprio J, Olesen J, Russell MB (1999). “The relative role of genetic and environmental factors in migraine without aura”. Neurology. 53 (5): 995–9. PMID 10496258. Retrieved 2012-08-30. Unknown parameter
|month=ignored (help) - ↑ Lipton RB, Stewart WF, Celentano DD, Reed ML (1992). “Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis”. Arch. Intern. Med. 152 (6): 1273–8. PMID 1599358.
- ↑ Schreiber CP, Hutchinson S, Webster CJ, Ames M, Richardson MS, Powers C (2004). “Prevalence of migraine in patients with a history of self-reported or physician-diagnosed “sinus” headache”. Arch. Intern. Med. 164 (16): 1769–72. doi:10.1001/archinte.164.16.1769. PMID 15364670.
- ↑ 11.0 11.1 Goadsby PJ, Lipton RB, Ferrari MD (2002). “Migraine–current understanding and treatment”. N Engl J Med. 346 (4): 257–70. doi:10.1056/NEJMra010917. PMID 11807151.
- ↑ Bartleson JD, Cutrer FM (May 2010). “Migraine update. Diagnosis and treatment”. Minn Med. 93 (5): 36–41. PMID 20572569.
- ↑ 13.0 13.1 The Headaches Chp. 29, Pg. 276
- ↑ Goadsby, PJ (January 2009). “The vascular theory of migraine – a great story wrecked by the facts”. Brain : a journal of neurology. 132 (Pt 1): 6–7. doi:10.1093/brain/awn321. PMID 19098031.
- ↑ Brennan, KC (June 2010). “An update on the blood vessel in migraine”. Current Opinion in Neurology. 23 (3): 266–74. doi:10.1097/WCO.0b013e32833821c1. PMID 20216215. Unknown parameter
|coauthors=ignored (help) - ↑ Dodick, DW (April 2008). “Examining the essence of migraine – is it the blood vessel or the brain? A debate”. Headache. 48 (4): 661–7. doi:10.1111/j.1526-4610.2008.01079.x. PMID 18377395.
- ↑ 17.0 17.1 17.2 Gilmore B, Michael M (2011). “Treatment of acute migraine headache”. Am Fam Physician. 83 (3): 271–80. PMID 21302868.
- ↑ . Silberstein S. “Migraine”. Lancet 2004;363:381-391
- ↑ Kurth T, Chabriat H, Bousser MG (2012). “Migraine and stroke: a complex association with clinical implications”. Lancet Neurol. 11 (1): 92–100. doi:10.1016/S1474-4422(11)70266-6. PMID 22172624.
- ↑ Lanteri-Minet M, Valade D, Geraud G, Lucas C, Donnet A (2014). “Revised French guidelines for the diagnosis and management of migraine in adults and children”. J Headache Pain. 15 (1): 2. doi:10.1186/1129-2377-15-2. PMID 24400971.
- ↑ Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E; et al. (2012). “Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society”. Neurology. 78 (17): 1337–45. doi:10.1212/WNL.0b013e3182535d20. PMC 3335452. PMID 22529202.
- ↑ Modi S, Lowder DM (2006). “Medications for migraine prophylaxis”. Am Fam Physician. 73 (1): 72–8. PMID 16417067.
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The word migraine is French in origin and comes from the Greek hemicrania, as does the Old English term megrim. Literally, hemicrania means “half (the) head.”
Historical Perspective
An early description consistent with migraines is contained in the Ebers papyrus, written around 1500 BCE in ancient Egypt.[1] In 200 BCE, writings from the Hippocratic school of medicine described the visual aura that can precede the headache and a partial relief occurring through vomiting.[2] A second-century description by Aretaeus of Cappadocia divided headaches into three types: cephalalgia, cephalea, and heterocrania.[3] Galen of Pergamon used the term hemicrania (half-head), from which the word migraine was eventually derived.[3] He also proposed that the pain arose from the meninges and blood vessels of the head.[2] Migraines were first divided into the two now used types – migraine with aura (migraine ophthalmique) and migraine without aura (migraine vulgaire) in 1887 by Louis Hyacinthe Thomas, a French Librarian.[2]

Trepanation, the deliberate drilling of holes into a skull, was practiced as early as 7,000 BCE.[1] While sometimes people survived, many would have died from the procedure due to infection.[4] It was believed to work via “letting evil spirits escape”.[5] William Harvey recommended trepanation as a treatment for migraines in the 17th century.[6]
While many treatments for migraines have been attempted, it was not until 1868 that use of a substance which eventually turned out to be effective began.[2] This substance was the fungus ergot from which ergotamine was isolated in 1918.[7] Methysergide was developed in 1959 and the first triptan, sumatriptan, was developed in 1988.[7] During the 20th century with better study design effective preventative measures were found and confirmed.[2]
Shown below is an image depicting ‘The Head Ache’ by George Cruikshank.
References
- ↑ 1.0 1.1 Miller, Neil (2005). Walsh and Hoyt’s clinical neuro-ophthalmology (6 ed.). Philadelphia, Pa.: Lippincott Williams & Wilkins. p. 1275. ISBN 9780781748117.
- ↑ 2.0 2.1 2.2 2.3 2.4 Borsook, David (2012). The migraine brain : imaging, structure, and function. New York: Oxford University Press. pp. 3–11. ISBN 9780199754564.
- ↑ 3.0 3.1 Waldman, [edited by] Steven D. (2011). Pain management (2 ed.). Philadelphia, PA: Elsevier/Saunders. pp. 2122–2124. ISBN 9781437736038.
- ↑ Mays, eds. Margaret Cox, Simon (2002). Human osteology : in archaeology and forensic science (Repr. ed.). Cambridge [etc.]: Cambridge University Press. p. 345. ISBN 9780521691468.
- ↑ Colen, Chaim (2008). Neurosurgery. Colen Publishing. p. 1. ISBN 9781935345039.
- ↑ Daniel, Britt Talley (2010). Migraine. Bloomington, IN: AuthorHouse. p. 101. ISBN 9781449069629.
- ↑ 7.0 7.1 Tfelt-Hansen, PC (May 2011). “One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010”. Headache. 51 (5): 752–78. doi:10.1111/j.1526-4610.2011.01892.x. PMID 21521208. Unknown parameter
|coauthors=ignored (help)
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Migraines can be divided in three different types: migraine without aura, typical migraine with aura and probable migraine without aura. Migraines are often underdiagnosed and misdiagnosed.[1][2] The diagnostic criteria for migraine include recurrent headache disorder manifesting in attacks that fulfill typical characteristics in a context of normal clinical examination that rules out other diagnoses. Migraine with aura is a recurrent disorder manifesting in attacks of reversible focal neurological symptoms that usually develop gradually over 5–20 minutes and last for less than 60 minutes.
The International Classification of Headache Disorders (ICHD)
Migraine without Aura
The diagnosis of migraine without aura, according to the International Headache Society, can be made according to the following criteria:[3]
- A – ≥ 5 attacks characterized by the symptoms presented in the criteria B through D
- B – Headaches can last form 4 to 72 hours.
- C – Headaches must contain at least one of the following:
- Unilateral location
- Pulsating quality
- Moderate to severe pain
- Aggravation or causing of the pain from normal physical activity
- D – Presence of one of the following:
- Nausea and/or vomit
- Photophobia and/or phonophobia
- E – The symptoms can not be better accounted for by any other diagnosis.
The mnemonic POUNDing (Pulsating, duration of 4-72 hOurs, Unilateral, Nausea, Disabling) can help diagnose migraine. If 4 of the 5 criteria are met, then the positive likelihood ratio for diagnosing migraine is 24.[4]. The presence of either disability, nausea or sensitivity, can diagnose migraine with[5] sensitivity of 81% and specificity of 75%. Patients that meet the criterai for Migraine without aura, but have fewer than 5 attacks, are classified as Probable Migraine without aura.
Migraine with Aura
The diagnosis of migraine with aura, according to the International Headache Society, can be made according to the following criteria:[3]
- A – ≥ 2 attacks characterized by the symptoms presented in the criteria B through D
- B – At least 1 of the following reversible symptoms:
- C – At least two of the following:
- D – The symptoms can not be better accounted for by any other diagnosis.
Where these criteria are not fully met, a diagnosis of “probable migraine with aura” may be considered, although other neurological causes must also be excluded.
If the picture complies with the criteria but includes one-sided muscular weakness or paralysis, a diagnosis of “sporadic hemiplegic migraine” or “familial hemiplegic migraine” should be considered.
| Typical aura With migraine headache | Typical aura with migraine headache consists of a typical aura involving visual and/or sensory and/or speech symptoms, lasting no more than 60 minutes. The aura is characterized by complete reversibility of the symptoms and is associated with headache fulfilling the criteria for migraine without aura. It begins during the aura or follow the aura within 60 minutes and is not attributed to another disorder. |
| Typical aura with non-migraine headache | Is a typical aura involving visual and/or sensory and/or speech symptoms, lasting no more than 60 minutes. The aura is characterized by complete reversibility of the symptoms, which is associated with headache that does not fulfil the criteria for migraine without aura. |
| Typical aura without headache | Is a typical aura involving visual and/or sensory and/or speech symptoms, lasting no more than 60 minutes. The aura is characterized by complete reversibility of the symptoms, which is not associated with headache. |
| Familial hemiplegic migraine (FHM) | Familial hemiplegic migraine (FHM) is a type of migraine with a possible polygenetic component. These migraine attacks may last 4-72 hours[6] and are apparently caused by ion channel mutations, three types of which have been identified to date. Patients who experience this syndrome have relatively typical migraine headaches preceded and/or accompanied by reversible limb weakness on one side as well as visual, sensory or speech difficulties. |
| Sporadic hemiplegic migraine | Sporadic hemiplegic migraine (SHM) have migraine attacks that may last 4-72 hours[6]. Patients who experience this syndrome have relatively typical migraine headaches preceded and/or accompanied by reversible limb weakness on one side as well as visual, sensory or speech difficulties without a first or second relative with hemiplegic migraine. |
| Basilar-type migraine | Basilar type migraine (BTM), formerly known as basilar artery migraine (BAM) or basilar migraine (BM), is an uncommon type of complicated migraine with aura. In the majority of migraineurs the aura progress gradually for 5 minutes or more, lasting 5 – 120 minutes and the headache starts after the onset of the aura.[7] The symptoms are originated from the brain stem and/or from both hemispheres simultaniously attacked, without weakness.[8] It always present 2 or more brain stem related aura symptoms (eg. Dysarthria, vertigo, hypoacusis, diplopia, ataxia, decreased level of consciousness) .[9] Serious episodes of BTM can lead to stroke, coma, or even death. The use of triptans and other vasoconstrictors as abortive treatments in BTM is contraindicated. Abortive treatments for BTM often focus on vasodilation and restoration of normal blood flow to the vertebrobasilar territory and subsequent return of normal brain stem function. |
Childhood Periodic Syndromes That Are Commonly Precursors Of Migraine
Cyclical Vomiting
Are recurrent episodic attacks that last from 1 hour to 5 days of nausea and vomiting at least 4 times per hour, free of symptoms between attacks and it is not attributed to another disorder.
Abdominal migraine
Is a recurrent disorder of unknown origin which occurs mainly in children. It is characterised by episodes of moderate to severe central abdominal pain lasting 1-72 hours. There is usually associated nausea and vomiting but the child is entirely well between attacks. In order to diagnose abdominal migraine, there must be at least five attacks, not attributable to another cause, fulfilling the following criteria
1. Attacks lasting 1-72 hours when untreated
2. Pain must have ALL of the following characteristics
- Location in the midline, around the umbilicus or poorly localised
- Dull or ‘just sore’ quality
- Moderate or severe intensity
3. During an attack there must be at least two of the following
Most children with abdominal migraine will develop migraine headache later in life and the two may co-exist during adolescence.
Bening paroxysmal Vertigo Of Childhood
Are recurrent brief episodic attacks of vertigo. In order to diagnose benign paroxysmal vertigo of childhood there must have been at least 5 attacks of multiple episodes with severe vertigo, starting without warning and resolving spontaneously. The patient must have a normal neurological, audiometric and vestibular functions between attacks and a normal electroencephalogram.
Retinal Migraine
Also called ocular migraine is a rare condition described as multiples attacks of monocular scotoma or blindness. In order to diagnose retinal migraine there must have been at least 2 attacks with reversible monocular (positive and/or negative) visual phenomena (eg, scotoma or blindness) and a headache fulfilling criteria for Migraine without aura begins during the visual symptoms or follows them within 60 minutes. The patient should have normal ophthalmological examination between attacks and is not attributed to another disorder.
References
- ↑ Lipton RB, Stewart WF, Celentano DD, Reed ML (1992). “Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis”. Arch. Intern. Med. 152 (6): 1273–8. PMID 1599358.
- ↑ Schreiber CP, Hutchinson S, Webster CJ, Ames M, Richardson MS, Powers C (2004). “Prevalence of migraine in patients with a history of self-reported or physician-diagnosed “sinus” headache”. Arch. Intern. Med. 164 (16): 1769–72. doi:10.1001/archinte.164.16.1769. PMID 15364670.
- ↑ 3.0 3.1 Headache Classification Committee of the International Headache Society (IHS) (2013). “The International Classification of Headache Disorders, 3rd edition (beta version)”. Cephalalgia. 33 (9): 629–808. doi:10.1177/0333102413485658. PMID 23771276.
- ↑ Detsky ME, McDonald DR, Baerlocher MO, Tomlinson GA, McCrory DC, Booth CM (2006). “Does this patient with headache have a migraine or need neuroimaging?”. JAMA. 296 (10): 1274–83. doi:10.1001/jama.296.10.1274. PMID 16968852.
- ↑ Lipton RB, Dodick D, Sadovsky R; et al. (2003). “A self-administered screener for migraine in primary care: The ID Migraine validation study”. Neurology. 61 (3): 375–82. PMID 12913201.
- ↑ 6.0 6.1 “The International Classification of Headache Disorders: 2nd edition”. Cephalalgia : an International Journal of Headache. 24 Suppl 1: 9–160. 2004. PMID 14979299. Retrieved 2012-08-30.
- ↑ name=”pmid23771276″>Headache Classification Committee of the International Headache Society (IHS) (2013). “The International Classification of Headache Disorders, 3rd edition (beta version)”. Cephalalgia. 33 (9): 629–808. doi:10.1177/0333102413485658. PMID 23771276.
- ↑ name=”pmid3537212″>Pearce JM (1986). “Historical aspects of migraine”. J Neurol Neurosurg Psychiatry. 49 (10): 1097–103. PMC 1029040. PMID 3537212.
- ↑ name=”pmid23771276″>Headache Classification Committee of the International Headache Society (IHS) (2013). “The International Classification of Headache Disorders, 3rd edition (beta version)”. Cephalalgia. 33 (9): 629–808. doi:10.1177/0333102413485658. PMID 23771276.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Migraines are believed to be a neurovascular disorder[1][2] with evidence supporting its mechanisms starting within the brain and then spreading to the blood vessels.[3] Migraine begins by neuronal changes leading to the activation of the brainstem and diencephalic nuclei and subsequent dilatation of the large cranial and proximal intracranial vessels.[1] Some researchers feel neuronal mechanisms play a greater role,[4] while others feel blood vessels play the key role.[5] Others feel both are likely important.[6] High levels of the neurotransmitter serotonin, also known as 5-hydroxytryptamine, are believed to be involved.[3]
Pathophysiology
Aura
Cortical spreading depression or spreading depression of Leão is bursts of neuronal activity followed by a period of inactivity, which is seen in those with migraines with an aura.[7] There are a number of explanations for its occurrence including activation of NMDA receptors leading to calcium entering the cell.[7] After the burst of activity the blood flow to the cerebral cortex in the area affected is decreased for two to six hours.[7] It is believed that when depolarization travels down the underside of the brain, nerves that sense pain in the head and neck are triggered.[7]
Shown below is an image depicting cortical spreading depression which is the underlying pathophysiology of aura.
Pain
The exact mechanism of the head pain which occurs during a migraine is unknown.[8] Some evidence supports a primary role for central nervous system structures (such as the brainstem and diencephalon)[9] while other data support the role peripheral activation (such as via the sensory nerves that surround blood vessels of the head and neck).[8] The potential candidate vessels include dural arteries, pial arteries and extracranial arteries such as those of the scalp.[8] The role of vasodilatation of the extracranial arteries, in particular, is believed to be significant.[10]
Genetics
Studies of twins indicate a 34% to 51% genetic influence of likelihood to develop migraine headaches.[11] This genetic relationship is stronger for migraines with aura than for migraines without aura. A number of specific variants of genes increase the risk by a small to moderate amount.[12]
Single gene disorders that result in migraines are rare.[12] One of these is known as familial hemiplegic migraine, a type of migraine with aura, which is inherited in anautosomal dominant fashion.[13][14] Four genes have been shown to be involved in familial hemiplegic migraine.[15] Three of these genes are involved in ion transport.[15] The fourth is an axonal protein associated with the exocytosis complex.[15] Another genetic disorder associated with migraine is CADASIL syndrome or cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.[16]
Evolution
Defense mechanism
The tendency to develop head pain when faced with a stressor or strong sensory stimuli can be explained in two ways. First, it may be a side effect of other CNS processes that provide important evolutionary advantages. One example is counteracting the dilation of cranial arteries to counteract dangerous vasoconstriction in the brain.[17] Second, migraine may be an example of how pain has evolved to encourage organisms to avoid potentially harmful situations. Olfactory-induced migraines (migraines stimulated by strong smells) have been explained as an attempt to interrupt the entry of toxins into the brain via the olfactory nerve.[18] Similarly, the low threshold for nausea and vomiting may be a mechanism to enhance elimination of ingested toxins in food. Migraineurs have a lower prevalence of malignant neoplasms in the brain than controls, suggesting that migraines are protective against tumors. However, the mechanism responsible for this difference is unknown.[19]
Conflicts with other organisms
A headache-prone CNS may have resulted from interactions with other organisms in two ways. The first possibility is that migraine offers an advantage to the organism in fighting infection by increasing blood flow to the brain. The second possibility is that certain pathogens evolved to cause headache as a way of speeding their transmission to other organisms.[20] Finally, migraine may benefit neither the host nor the pathogen, but may simply be the result of certain infections.[21] This last explanation is concordant with the apparent negative impact of migraine on human fitness.
Novel environmental factors
Modern environmental factors, with an increased sensory overload, may be especially permissive of the expression of genes that predispose for the disorder. If so, natural selection may not have had a chance to eliminate these genes yet. The increasing prevalence of migraine is easily a result of increased known triggers, such as bright light, loud noise, altered sleep/wake patterns, and emotional stress. This is an example of mismatch theory, which states that the current environment differs from the evolutionary environment of a particular trait.[20]
Genetic harms and benefits
Migraine is influenced on a polygenetic level (controlled by multiple genes). Therefore, researchers have theorized that migraine is a tradeoff and that it exists as a spectrum of susceptibility, with the majority of the population falling in the “heterozygous” zone between the two extremes of experiencing no headache and experiencing frequent, incapacitating headache. While it is not known for certain how or whether mild forms of the disorder would enhance survival, there is evidence of enhanced visual sensitivity in family members of migraineurs.[22] Additionally, this compromise theory may explain the higher prevalence among women, especially pregnant women and women of reproductive age (25-40). The avoidance of threatening environments is historically more important to the reproductive success of women.[23] The compromise between genetic harms and benefits is commonly seen in other disorders, such as cystic fibrosis and sickle cell anemia.
Headache as a design construct
Finally, migraine may be a component of imperfect central nervous system design. Evidence has suggested a dysfunction of pain-inhibitory pathways in migraine and discordant interaction between the ancient brain stem design and the more evolved neocortex.[24] The brain stem may be unable to suppress excessive input from higher brain centers.
References
- ↑ 1.0 1.1 Goadsby PJ, Lipton RB, Ferrari MD (2002). “Migraine–current understanding and treatment”. N Engl J Med. 346 (4): 257–70. doi:10.1056/NEJMra010917. PMID 11807151.
- ↑ Bartleson JD, Cutrer FM (May 2010). “Migraine update. Diagnosis and treatment”. Minn Med. 93 (5): 36–41. PMID 20572569.
- ↑ 3.0 3.1 The Headaches Chp. 29, Pg. 276
- ↑ Goadsby, PJ (January 2009). “The vascular theory of migraine – a great story wrecked by the facts”. Brain : a journal of neurology. 132 (Pt 1): 6–7. doi:10.1093/brain/awn321. PMID 19098031.
- ↑ Brennan, KC (June 2010). “An update on the blood vessel in migraine”. Current Opinion in Neurology. 23 (3): 266–74. doi:10.1097/WCO.0b013e32833821c1. PMID 20216215. Unknown parameter
|coauthors=ignored (help) - ↑ Dodick, DW (April 2008). “Examining the essence of migraine – is it the blood vessel or the brain? A debate”. Headache. 48 (4): 661–7. doi:10.1111/j.1526-4610.2008.01079.x. PMID 18377395.
- ↑ 7.0 7.1 7.2 7.3 The Headaches, Chp. 28, pp. 269–72
- ↑ 8.0 8.1 8.2 Olesen, J (July 2009). “Origin of pain in migraine: evidence for peripheral sensitization”. Lancet neurology. 8 (7): 679–90. doi:10.1016/S1474-4422(09)70090-0. PMID 19539239. Unknown parameter
|coauthors=ignored (help) - ↑ Akerman, S (2011-09-20). “Diencephalic and brainstem mechanisms in migraine”. Nature Reviews Neuroscience. 12 (10): 570–84. doi:10.1038/nrn3057. PMID 21931334. Unknown parameter
|coauthors=ignored (help) - ↑ Shevel, E (March 2011). “The extracranial vascular theory of migraine – a great story confirmed by the facts”. Headache. 51 (3): 409–17. doi:10.1111/j.1526-4610.2011.01844.x. PMID 21352215.
- ↑ Piane, M (December 2007). “Genetics of migraine and pharmacogenomics: some considerations”. The journal of headache and pain (Review). 8 (6): 334–9. doi:10.1007/s10194-007-0427-2. PMC 2779399. PMID 18058067. Unknown parameter
|coauthors=ignored (help) - ↑ 12.0 12.1 Schürks, M (January 2012). “Genetics of migraine in the age of genome-wide association studies”. The journal of headache and pain (Review). 13 (1): 1–9. doi:10.1007/s10194-011-0399-0. PMC 3253157. PMID 22072275.
- ↑ de Vries, B (July 2009). “Molecular genetics of migraine”. Human Genetics (Review). 126 (1): 115–32. doi:10.1007/s00439-009-0684-z. PMID 19455354. Unknown parameter
|coauthors=ignored (help) - ↑ Montagna, P (September 2008). “Migraine genetics”. Expert Review of Neurotherapeutics (Review). 8 (9): 1321–30. doi:10.1586/14737175.8.9.1321. PMID 18759544.
- ↑ 15.0 15.1 15.2 Ducros, A (Apr 22, 2013). “[Genetics of migraine]”. Revue neurologique. 169 (5): 360–71. doi:10.1016/j.neurol.2012.11.010. PMID 23618705.
- ↑ Aminoff, Roger P. Simon, David A. Greenberg, Michael J. (2009). Clinical neurology (7 ed.). New York, N.Y: Lange Medical Books/McGraw-Hill. pp. 85–88. ISBN 9780071664332.
- ↑ Edvinsson, L. (1 October 1995). “Modification of vasoconstrictor responses in cerebral blood vessels by lesioning of the trigeminal nerve: possible involvement of CGRP”. Cephalalgia. 15 (5): 373–383. doi:10.1046/j.1468-2982.1995.1505373.x. PMID 8536296. Unknown parameter
|coauthors=ignored (help) - ↑ Covelli, Vito (1 January 1994). “Could migraine be a “protective factor” against tumors?”. International Journal of Neuroscience. 75 (1–2): 139–143. doi:10.3109/00207459408986297. PMID 8050847. Unknown parameter
|coauthors=ignored (help) - ↑ Snyder, RD (1 November 1997). “Olfaction in migraine”. Cephalalgia (Clinical trial). 17 (7): 729–732. doi:10.1046/j.1468-2982.1997.1707729.x. PMID 9399001. Unknown parameter
|coauthors=ignored (help) - ↑ 20.0 20.1 Invalid
<ref>tag; no text was provided for refs namedLoder2002 - ↑ Cochran, Gregory M (1 January 2000). “Infectious causation of disease: an evolutionary perspective”. Perspectives in Biology and Medicine (Historical article). 43 (3): 406–448. doi:10.1353/pbm.2000.0016. PMID 10893730. Unknown parameter
|coauthors=ignored (help) - ↑ Puca, F. (1 June 1996). “Photic driving in migraine: correlations with clinical features”. Cephalalgia. 16 (4): 246–250. doi:10.1046/j.1468-2982.1996.1604246.x. PMID 8792036. Unknown parameter
|coauthors=ignored (help) - ↑ Stewart, Walter F. (1 January 1992). “Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors”. JAMA: The Journal of the American Medical Association. 267 (1): 64. doi:10.1001/jama.1992.03480010072027. PMID 1727198.
- ↑ Weiller, C (July 1995). “Brain stem activation in spontaneous human migraine attacks”. Nature medicine. 1 (7): 658–60. PMID 7585147. Unknown parameter
|coauthors=ignored (help)
Triggers
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
A migraine trigger is any factor that, on exposure or withdrawal, leads to the development of an acute migraine headache. Triggers may be categorized as behavioral, environmental, infectious, dietary, chemical, or hormonal.In the medical literature, these factors are known as precipitants. Many people report that one or more dietary, physical, hormonal, emotional, or environmental factors precipitate their migraines. The most-often reported triggers include: pesticides (sprayed fruits/vegetables), perfumes or fragrances (30% of sufferers) stress, over-illumination or glare, alcohol, foods, too much or too little sleep, and weather. Some women experience migraines in conjunction with monthly menstrual cycles. Sometimes the migraine occurs with no apparent “cause”. The trigger theory supposes that exposure to various environmental factors precipitates, or triggers, individual migraine episodes. Migraine patients have long been advised to try to identify personal headache triggers by looking for associations between their headaches and various suspected trigger factors. Patients are urged to keep a “headache diary” in which to note what they eat and when they get a headache, to look for correlations, and to try to avoid headache by avoiding factors they identify as triggers. Typically this advice is accompanied by a list of trigger factors.
Triggers
Shown below is a list of migraine attacks triggers according to the National Library of Medicine’s Medical Encyclopedia:
- Allergic reactions
- Bright lights, loud noises, and certain odors or perfumes
- Physical or emotional stress
- Changes in sleep patterns
- Smoking or exposure to smoke
- Skipping meals
- Alcohol or caffeine
- Menstrual cycle fluctuations, birth control pills
- Exposure to pesticides (sprayed fruits/vegetables)
- Tension headaches Headache
- Foods containing tyramine (red wine, aged cheese, smoked fish, chicken livers, figs, and some beans), monosodium glutamate (MSG), or nitrates (like bacon, hot dogs, and salami)
- Other foods such as chocolate, nuts, peanut butter, avocado, banana, citrus, onions, dairy products, and fermented or pickled foods.[1]
- Drugs like Apremilast, conjugated estrogens, Cidofovir
Cervicogenic Headache
It is very common for patients with migraine to have an associated musculoskeletal component. This portion of the migraine may be perceived as due to tension (which may in fact be a trigger in and of itself), an old neck injury that the afflicted does not realize can cause migraine like headache or degenerative changes in the neck. Less obvious sources of cervicogenic Headache may be postural related. For example in the presence of an old ankle injury center of gravity can be shifted forward. As a result, the neck must be held in extension in order to stand up right. In this instance every step taken aggravates the condition [2].
Food
In 2005, authors who reviewed the medical literature[3] found that the available information about dietary trigger factors relies mostly on the subjective assessments of patients. Some suspected dietary trigger factors appear to genuinely promote or precipitate migraine episodes, but many other suspected dietary triggers have never been demonstrated to trigger migraines. The review authors found that alcohol, caffeine withdrawal, and missing meals are the most important dietary migraine precipitants. The authors say dehydration deserves more attention, and that some patients report sensitivity to red wine. The authors found little or no demonstrated evidence that notorious suspected triggers chocolate, cheese, or that histamine, tyramine, nitrates, or nitrites normally present in foods trigger headaches. The artificial sweetener aspartame (NutraSweet®) has not been shown to trigger headache, but in a large and definitive study monosodium glutamate (MSG) in large doses (2.5 grams) was associated with adverse symptoms including headache more often than was placebo. The review authors also note that while general dietary restriction has not been demonstrated to be an effective migraine therapy, it is beneficial for the individual to avoid what has been a definite cause of the migraine.On the other hand, several headache clinics have had good results with individually tailored dietary restriction as a therapy. Dr. Ian Livingstone, director of the Princeton Headache Clinic, recommends eliminating the following common headache triggers from the diet: aged cheese, monosodium glutamate, processed fish and meats containing nitrates (such as hot dogs), dark chocolate, aspartame, certain alcoholic beverages (including red wine), citrus fruits, and caffeine. After a period of one to two months, these foods can be reintroduced one at a time to determine their trigger potential for that individual. Adding large amounts of the suspected trigger in a short time may generate a response that is easy to observe.Dr. David Buchholz, a neurologist who treats headaches at Johns Hopkins Hospital, has a longer list of suspected migraine triggers. He also recommends eliminating the triggers from the diet altogether, and then reintroducing them slowly after many weeks to measure the effects. His list includes: coffee (including decaf), chocolate, monosodium glutamate, processed meats and fish (aged, canned, preserved, processed with nitrates, and some meats that contain tyramine), cheese and dairy products (the more aged, the worse), nuts, citrus and some other fruits, certain vegetables (especially onions), fresh risen yeast baked goods, dietary sources of tyramine (including the foods listed above), and whatever gives you a headache. The National Headache Foundation has a more specific list of triggers based on the tyramine theory, which differs slightly from David Buchholz’s list. For example, it says that decaffeinated coffee is allowed. The list details “Allowed”, “Use with caution”, and “Avoid” triggers.[4]
Weather
Several studies have found some migraines are triggered by changes in weather. One study[5] noted that 62% of the subjects in the study thought that weather was a factor, in fact 51% were actually sensitive to weather changes. Among those whose migraines did occur during a change in weather, the subjects often picked a weather change other than the actual weather data recorded. Most likely to trigger a migraine were, in order:
- Temperature mixed with humidity. High humidity plus high or low temperature was the biggest cause.
- Significant changes in weather
- Changes in barometric pressure (See Abortive Treatment)
Another study[6]‘ researched whether chinook winds (warm westerly winds occurring along the Front Ranges of the Rocky Mountains) are a migraine trigger. Many patients had increased incidence of migraines immediately before and/or during the chinook winds. The number of people reporting migrainous episodes during the chinook winds was higher on high-wind chinook days. The probable cause is “through increased air positive ion concentrations.” In the 40’s the Lancet published the first article on “Barre lieou“. This is a weather sensitive headache syndrome associated with blurred vision, ringing in the ears, dizziness and nausea. It is also referred to as The Posterior Cervical Sympathetic Syndrome of Barre-Lieou [2]. Sympathetic galvonic skin response studies utilizing infrared imaging have been reported to be helpful in the diagnosis of this syndrome.
Hair Wash Headache
Another trigger for migraine has been proposed by Dr.K.Ravishankar, a neurologist and headache specialist from India. He reported an unusual trigger for migraine seen among Indian women, Hair Wash Headache. It is described as a migraine headache that originates with a head bath. Most Indian women have long hair and so they wash their hair two or three times a week. Very often they do not use a hair dryer and often plait their hair when wet. This results in a gradual build up of pain which ultimately results in migraine.[7]
Drugs
References
- ↑ http://www.nlm.nih.gov/medlineplus/ency/article/000709.htm
- ↑ “Migraine”. Retrieved 2012-08-30.
- ↑ Holzhammer J, Wober C (2006). “[Alimentary trigger factors that provoke migraine and tension-type headache]”. Schmerz. 20 (2): 151–9. PMID 15806385.
- ↑ “Low Tyramine Headache Diet” (116 Kb PDF). National Headache Foundation. 2004. p. 2. Retrieved 2006-10-12. Unknown parameter
|month=ignored (help) - ↑ Prince PB, Rapoport AM, Sheftell FD, Tepper SJ, Bigal ME (2004). “The effect of weather on headache”. Headache. 44 (6): 596–602. PMID 15186304. Retrieved 2006-05-06.
- ↑ Cooke LJ, Rose MS, Becker WJ (2000). “Chinook winds and migraine headache”. Neurology. 54 (2): 302–7. PMID 10668687.
- ↑ Ravishankar, K (2006). “‘Hair wash’ or ‘Head bath’ triggering migraine – observations in 94 Indian patients”. Cephalagia. 26 (11): 1330–1334. ISSN 0333-1024.
Differentiating Migraine from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Other conditions that can cause similar symptoms to a migraine headache include temporal arteritis, cluster headaches, acute glaucoma, meningitis and subarachnoid hemorrhage.[1] Temporal arteritis typically occurs in people over 50 years old and presents with tenderness over the temple, cluster headaches presents with one-sided nose stuffiness, tears and severe pain around the orbits, acute glaucoma is associated with vision problems, meningitis with fevers, and subaracchnoid hemorrhage with a very fast onset.[1] Tension headaches typically occur on both sides, are not pounding, and are less disabling.[1]
Differentiating Migraine From Other Diseases
Migraine should be differentiated from other diseases causing severe headache for example: [2][3][4][5][6][7][8][9][10][11]
| Disease | Symptoms | Gold Standard | CT/MRI | Other Investigation Findings | ||
|---|---|---|---|---|---|---|
| Headache | Other features | |||||
| Onset | Characterstics | |||||
| Migraine | Sudden |
|
|
— | Migraine is a clinical diagnosis that does not require any laboratory tests. Laboratory tests can be ordered to rule out any suspected coexistent metabolic problems or to determine the baseline status of the patient before initiation of migraine therapy. | |
| Subarachnoid hemorrhage | Sudden |
|
|
Digital subtraction angiography |
|
|
| Meningitis | Sudden | Headache is associated with: | Lumbar puncture for CSF |
|
| |
| Intracranial mass | Gradual | Morning headache |
|
MRI |
|
|
| Cerebral hemorrhage | Sudden | Rapidly progressing headache |
|
CT without contrast
(differentiate ischemic stroke from hemorrhagic stroke.) |
|
|
| Intracranial venous thrombosis | Gradual |
|
|
Digital subtraction angiography |
|
|
| Head injury | Sudden |
|
|
CT scan without contrast |
|
|
| Lymphocytic hypophysitis | Sudden |
|
|
Pituitary biopsy |
| |
Migraine must be differentiated from other causes of headache,seizures and loss of consciousness.
| Diseases | Symptoms | Physical Examination | Past medical history | Diagnostic tests | Other Findings | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Headache | ↓LOC | Motor weakness | Abnormal sensory | Motor Deficit | Sensory deficit | Speech difficulty | Gait abnormality | Cranial nerves | CT /MRI | CSF Findings | Gold standard test | |||
| Meningitis | + | – | – | – | – | + | + | – | – | History of fever and malaise | – | ↑ Leukocytes,
↑ Protein ↓ Glucose |
CSF analysis[12] | Fever, neck |
| Encephalitis | + | + | +/- | +/- | – | – | + | +/- | + | History of fever and malaise | + | ↑ Leukocytes, ↓ Glucose | CSF PCR | Fever, seizures, focal neurologic abnormalities |
| Brain tumor[13] | + | – | – | – | + | + | + | – | + | Weight loss, fatigue | + | Cancer cells[14] | MRI | Cachexia, gradual progression of symptoms |
| Hemorrhagic stroke | + | + | + | + | + | + | + | + | – | Hypertension | + | – | CT scan without contrast[15][16] | Neck stiffness |
| Subdural hemorrhage | + | + | + | + | + | – | – | – | + | Trauma, fall | + | Xanthochromia[17] | CT scan without contrast[15][16] | Confusion, dizziness, nausea, vomiting |
| Neurosyphilis[18][19] | + | – | + | + | + | + | – | + | – | STIs | + | ↑ Leukocytes and protein | CSF VDRL-specifc
CSF FTA-Ab -sensitive[20] |
Blindness, confusion, depression,
Abnormal gait |
| Complex or atypical migraine | + | – | + | + | – | – | + | – | – | Family history of migraine | – | – | Clinical assesment | Presence of aura, nausea, vomiting |
| Hypertensive encephalopathy | + | + | – | – | – | – | + | + | – | Hypertension | + | – | Clinical assesment | Delirium, cortical blindness, cerebral edema, seizure |
| Wernicke’s encephalopathy | – | + | – | – | – | + | + | + | + | History of alcohal abuse | – | – | Clinical assesment and lab findings | Ophthalmoplegia, confusion |
| CNS abscess | + | + | – | – | + | + | + | – | – | History of drug abuse, endocarditis, immunosupression | + | ↑ leukocytes, ↓ glucose and ↑ protien | MRI is more sensitive and specific | High grade fever, fatigue,nausea, vomiting |
| Drug toxicity | – | + | – | + | + | + | – | + | – | – | – | – | Drug screen test | Lithium, Sedatives, phenytoin, carbamazepine |
| Conversion disorder | + | + | + | + | + | + | + | + | History of emotional stress | – | – | Diagnosis of exclusion | Tremors, blindness, difficulty swallowing | |
| Metabolic disturbances (electrolyte imbalance, hypoglycemia) | – | + | + | + | + | + | – | – | + | – | – | Hypoglycemia, hypo and hypernatremia, hypo and hyperkalemia | Depends on the cause | Confusion, seizure, palpitations, sweating, dizziness, hypoglycemia |
| Multiple sclerosis exacerbation | – | – | + | + | – | + | + | + | + | History of relapses and remissions | + | ↑ CSF IgG levels
(monoclonal bands) |
Clinical assesment and MRI [21] | Blurry vision, urinary incontinence, fatigue |
| Seizure | + | + | – | – | + | + | – | – | + | Previous history of seizures | – | Mass lesion | Clinical assesment and EEG [22] | Confusion, apathy, irritability, |
References
- ↑ 1.0 1.1 1.2 Gilmore B, Michael M (2011). “Treatment of acute migraine headache”. Am Fam Physician. 83 (3): 271–80. PMID 21302868.
- ↑ Endrit Ziu & Fassil Mesfin (2017). “Subarachnoid Hemorrhage”. PMID 28722987.
- ↑ Benedikt Schwermer, Daniel Eschle & Constantine Bloch-Infanger (2017). “[Fever and Headache after a Vacation in Thailand]”. Deutsche medizinische Wochenschrift (1946). 142 (14): 1063–1066. doi:10.1055/s-0043-106282. PMID 28728201.
- ↑ Otto Rapalino & Mark E. Mullins (2017). “Intracranial Infectious and Inflammatory Diseases Presenting as Neurosurgical Pathologies”. Neurosurgery. doi:10.1093/neuros/nyx201. PMID 28575459.
- ↑ I. B. Komarova, V. P. Zykov, L. V. Ushakova, E. K. Nazarova, E. B. Novikova, O. V. Shuleshko & M. G. Samigulina (2017). “[Clinical and neuroimaging signs of cardioembolic stroke laboratory in children]”. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 117 (3. Vyp. 2): 11–19. doi:10.17116/jnevro20171173211-19. PMID 28665364.
- ↑ Sanjay Konakondla, Clemens M. Schirmer, Fengwu Li, Xiaogun Geng & Yuchuan Ding (2017). “New Developments in the Pathophysiology, Workup, and Diagnosis of Dural Venous Sinus Thrombosis (DVST) and a Systematic Review of Endovascular Treatments”. Aging and disease. 8 (2): 136–148. doi:10.14336/AD.2016.0915. PMID 28400981.
- ↑ Priyanka Yadav, Alec L. Bradley & Jonathan H. Smith (2017). “Recognition of Chronic Migraine by Medicine Trainees: A Cross-Sectional Survey”. Headache. doi:10.1111/head.13133. PMID 28653369.
- ↑ S. Wulffeld, L. S. Rasmussen, B. Hojlund Bech & J. Steinmetz (2017). “The effect of CT scanners in the trauma room – an observational study”. Acta anaesthesiologica Scandinavica. 61 (7): 832–840. doi:10.1111/aas.12927. PMID 28635146.
- ↑ Johnston PC, Chew LS, Hamrahian AH, Kennedy L (2015). “Lymphocytic infundibulo-neurohypophysitis: a clinical overview”. Endocrine. 50 (3): 531–6. doi:10.1007/s12020-015-0707-6. PMID 26219407.
- ↑ Makale MT, McDonald CR, Hattangadi-Gluth JA, Kesari S (2017). “Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours”. Nat Rev Neurol. 13 (1): 52–64. doi:10.1038/nrneurol.2016.185. PMID 27982041.
- ↑ Sato N, Sze G, Endo K (1998). “Hypophysitis: endocrinologic and dynamic MR findings”. AJNR Am J Neuroradiol. 19 (3): 439–44. PMID 9541295.
- ↑ Carbonnelle E (2009). “[Laboratory diagnosis of bacterial meningitis: usefulness of various tests for the determination of the etiological agent]”. Med Mal Infect. 39 (7–8): 581–605. doi:10.1016/j.medmal.2009.02.017. PMID 19398286.
- ↑ Morgenstern LB, Frankowski RF (1999). “Brain tumor masquerading as stroke”. J Neurooncol. 44 (1): 47–52. PMID 10582668.
- ↑ Weston CL, Glantz MJ, Connor JR (2011). “Detection of cancer cells in the cerebrospinal fluid: current methods and future directions”. Fluids Barriers CNS. 8 (1): 14. doi:10.1186/2045-8118-8-14. PMC 3059292. PMID 21371327.
- ↑ 15.0 15.1 Birenbaum D, Bancroft LW, Felsberg GJ (2011). “Imaging in acute stroke”. West J Emerg Med. 12 (1): 67–76. PMC 3088377. PMID 21694755.
- ↑ 16.0 16.1 DeLaPaz RL, Wippold FJ, Cornelius RS, Amin-Hanjani S, Angtuaco EJ, Broderick DF; et al. (2011). “ACR Appropriateness Criteria® on cerebrovascular disease”. J Am Coll Radiol. 8 (8): 532–8. doi:10.1016/j.jacr.2011.05.010. PMID 21807345.
- ↑ Lee MC, Heaney LM, Jacobson RL, Klassen AC (1975). “Cerebrospinal fluid in cerebral hemorrhage and infarction”. Stroke. 6 (6): 638–41. PMID 1198628.
- ↑ Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG; et al. (2012). “Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients”. J Neurol Sci. 317 (1–2): 35–9. doi:10.1016/j.jns.2012.03.003. PMID 22482824.
- ↑ Berger JR, Dean D (2014). “Neurosyphilis”. Handb Clin Neurol. 121: 1461–72. doi:10.1016/B978-0-7020-4088-7.00098-5. PMID 24365430.
- ↑ Ho EL, Marra CM (2012). “Treponemal tests for neurosyphilis–less accurate than what we thought?”. Sex Transm Dis. 39 (4): 298–9. doi:10.1097/OLQ.0b013e31824ee574. PMC 3746559. PMID 22421697.
- ↑ Giang DW, Grow VM, Mooney C, Mushlin AI, Goodman AD, Mattson DH; et al. (1994). “Clinical diagnosis of multiple sclerosis. The impact of magnetic resonance imaging and ancillary testing. Rochester-Toronto Magnetic Resonance Study Group”. Arch Neurol. 51 (1): 61–6. PMID 8274111.
- ↑ Manford M (2001). “Assessment and investigation of possible epileptic seizures”. J Neurol Neurosurg Psychiatry. 70 Suppl 2: II3–8. PMC 1765557. PMID 11385043.
Other Conditions causing headache
References
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Overview
Migraine is widespread in the population. The majority of migraine (as it is referred to commonly) is actually mixed Headache. In the U.S., 18% of women and 6% of men report having had at least one migraine episode in the previous year[1] According to reports, 10% of people have been diagnosed with migraine and 5% have migraine but have not been diagnosed, with seriousness varying from a rare annoyance to a life-threatening and/or daily experience.
Epidemiology and Demographics
Migraine is an extremely common condition which will affect 12-28% of people at some point in their lives.[2] However this figure — the lifetime prevalence — does not provide a very clear picture of how many patients there are with active migraine at any one time. Typically, therefore, the burden of migraine in a population is assessed by looking at the one-year prevalence — a figure that defines the number of patients who have had one or more attacks in the previous year. The third figure, which helps to clarify the picture, is the incidence — this relates to the number of first attacks occurring at any given age and helps understanding of how the disease grows and shrinks over time. Based on the results of a number of studies, one year prevalence of migraine ranges from 6-15% in adult men and from 14-35% in adult women.[3] These figures vary substantially with age: approximately 4-5% of children aged under 12 suffer from migraine, with little apparent difference between boys and girls.[4] There is then a rapid growth in incidence amongst girls occurring after puberty,[5][6][7] which continues throughout early adult life.[8] By early middle age, around 25% of women experience a migraine at least once a year, compared with fewer than 10% of men.[9][10] After menopause, attacks in women tend to decline dramatically, so that in the over 70s there are approximately equal numbers of male and female sufferers, with prevalence returning to around 5%.[2] At all ages, migraine without aura is more common than migraine with aura, with a ratio of between 1.5:1 and 2:1.[11][12] Incidence figures show that the excess of migraine seen in women of reproductive age is mainly due to migraine without aura.[13] Thus in pre-pubertal and post-menopausal populations, migraine with aura is somewhat more common than amongst 15-50 year olds[14][15]Geographical differences in migraine prevalence are not marked. Studies in Asia and South America suggest that the rates there are relatively low,[16][17] but they do not fall outside the range of values seen in European and North American studies.[18][19]The incidence of migraine is related to the incidence of epilepsy in families, with migraine twice as prevalent in family members of epilepsy sufferers, and more common in epilepsy sufferers themselves.[20]
Shown below is the age-standardised disability-adjusted life year (DALY) rates from Migraine by country (per 100,000 inhabitants).
References
- ↑ . Silberstein S. “Migraine”. Lancet 2004;363:381-391
- ↑ 2.0 2.1 Stovner LJ, Zwart J-A, Hagen K, et al. “Epidemiology of headache in Europe”. Eur J Neurol 2006;13:333-45
- ↑ name=”Stovner”
- ↑ 3. Mortimer MJ, Kay J, Jaron A. “Epidemiology of headache and childhood migraine in an urban general practice using ad hoc, Vahlquist and IHS criteria”. Dev Med Child Neurol 1992;34:1095-1101
- ↑ Linet MS, Stewart WF, Celentano DD et al. “An epidemiologic study of headache among adolescents and young adults”. JAMA 1989;261:2211-16
- ↑ Ziegler DK, Hassanein RS, Couch JR. “Characteristics of life headache histories in a nonclinic population”. Neurology 1977;27:265-269
- ↑ Selby G, Lance JW. “Observations on 500 cases of migraine and allied vascular headache”. J Neurol Neurosurg Psychiat 1960;23:23-32
- ↑ Anttila P, Metsahonkala L, Sillanpaa M. “Long-term trends in the incidence of headache in Finnish schoolchildren”. Pediatrics 2006;117:e1197-e1201
- ↑ name=”Stovner”
- ↑ name = “Lipton”>Lipton RB,.Stewart WF. Migraine in the United States: a review of epidemiology and health care use. Neurology 1993;43:S6-10
- ↑ Rasmussen BK,.Olesen J. “Migraine with aura and migraine without aura: an epidemiological study”. Cephalalgia 1992;12:221-8
- ↑ Steiner TJ, Scher AI, Stewart WF, et al. “The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity”. Cephalalgia 2003; 23:519-27
- ↑ Rasmussen BK,.Olesen J. “Migraine with aura and migraine without aura: an epidemiological study”. Cephalalgia 1992;12:221-8
- ↑ Anttila P, Metsahonkala L, Sillanpaa M. “Long-term trends in the incidence of headache in Finnish schoolchildren”. Pediatrics 2006;117:e1197-e12017,10
- ↑ Bigal ME, Liberman JN, Lipton RB. “Age-dependent prevalence and clinical features of migraine”. Neurology 2006;67:246-51
- ↑ Wang SJ. “Epidemiology of migraine and other types of headache in Asia”. Curr Neurol. Neurosci. Rep. 2003;3:104-8
- ↑ Lavados PM,.Tenhamm E. “Epidemiology of migraine headache in Santiago, Chile: a prevalence study”. Cephalalgia 1997;17:770-7
- ↑ name=”Stovner”
- ↑ Lipton RB,.Stewart WF. “Migraine in the United States: a review of epidemiology and health care use”. Neurology 1993;43:S6-10
- ↑ [1]‘Comorbidity of migraine and epilepsy’, Ottman, R and Lipton, R, Neurology, 1994
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The cause of migraine remains unknown. It seems that both genetics and environmental contribute to the cause. Risk factors for migraine include a young age, a female sex and a positive family history.
Risk Factors
- Family history of migraines
- Age less than 40 years
- Female
References
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Migraine with aura is associated with increased risk of subsequent stroke, a risk further amplified among females, smokers, patients on OCP and patients suffering from frequent migraine episodes. Despite the elevated risk of stroke among patients with migraine associated with aura, the incidence of stroke in this category of patients remain low particularly in young adults. Patients with migraine not associated with aura are not at an increased risk of stroke compared to the general population.[1]
Complications
- Status migrainosus: The migraine episode lasts more than 72 hours.
- Persistent aura without infarction: The symptoms of aura last for more than a week in the absence of any neuroimaging findings suggestive of infarction.
- Migrainous infarction: The symptoms of aura last for more than a week in the context of any neuroimaging findings suggestive of infarction in the corresponding brain territory.
- Seizure triggered by a migrainous aura[2]
Migraine and Stroke
The association between migraine and increased risk of subsequent stroke has long been suspected.[3] In fact, migraine with aura is associated with two times increase of ischemic stroke, while migraine without aura was not demonstrated to be linked to an increased risk of subsequent stoke. Although patients suffering from migraine with aura are at a double risk of ischemic stroke, the incidence of stroke remains a rare event particularly among young adults. The risk of subsequent stroke is higher among females and among patients suffering from a high frequency of migraine with aura episodes.[4] Some risk factors that predispose to stroke among migraine patients are smoking, OCP use and genetic mutations.[3][5][6] In addition, patients with patent foramen ovale and migraine are at increased risk of stroke. Closure of patent foramen ovale has been reported to improve migraine and therefore decrease the risk of subsequent stroke episodes; however, randomized clinical trials failed to demonstrate these benefits.[1]
The link between stroke and migraine is far more complicated than a simple risk or predisposition relationship. Migraine, as well as of stroke, involves changes in the vascular and neuronal structure of the brain. Therefore, it is difficult to differentiate whether stroke is a result of the aura of the primary migraine, or if it results from vascular abnormalities predisposing to both migraines and strokes. Some of the vascular abnormalities that are associated with migraines are AV malformations, moyamoya syndrome, hereditary telengectasia, lupus, antiphospholipid syndrome, cardiac myxoma among other vascular medical conditions. It is worth mentioning that migraine was not only associated with ischemic strokes, but also hemorrhagic strokes and lacunar infarcts.[1]
In addition, the underlying pathophysiology of aura is explained by a synchronized depression of the activity of neurons throughout the cortex of the brain causing not only electrolyte changes but also decrease in the cerebral blood flow. This decrease in the cerebral flow lowers the threshold for ischemic stroke. And vice versa, a decrease in the cerebral blood flow as in the case of hypoperfusion, ischemia or embolism leads to cellular changes predisposing to aura. This adds to the complexity of the association between stroke and migraine, which remains unclear.[1]
Prognosis
Many patients with migraine can relieve pain and reduce frenquency with treatments.
References
- ↑ 1.0 1.1 1.2 1.3 Kurth T, Chabriat H, Bousser MG (2012). “Migraine and stroke: a complex association with clinical implications”. Lancet Neurol. 11 (1): 92–100. doi:10.1016/S1474-4422(11)70266-6. PMID 22172624.
- ↑ Headache Classification Committee of the International Headache Society (IHS) (2013). “The International Classification of Headache Disorders, 3rd edition (beta version)”. Cephalalgia. 33 (9): 629–808. doi:10.1177/0333102413485658. PMID 23771276.
- ↑ 3.0 3.1 Etminan M, Takkouche B, Isorna FC, Samii A (2005). “Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies”. BMJ. 330 (7482): 63. doi:10.1136/bmj.38302.504063.8F. PMC 543862. PMID 15596418.
- ↑ Merikangas KR, Fenton BT, Cheng SH, Stolar MJ, Risch N (1997). “Association between migraine and stroke in a large-scale epidemiological study of the United States”. Arch Neurol. 54 (4): 362–8. PMID 9109736.
- ↑ Tzourio C, Tehindrazanarivelo A, Iglesias S, Alperovitch A, Chedru F, d’Anglejan-Chatillon J, Bousser MG (1995). “Case-control study of migraine and risk of ischaemic stroke in young women”. BMJ. 310 (6983): 830–3. PMID 7711619.
- ↑ Kurth, T (2006). “Migraine and risk of cardiovascular disease in women”. Journal of the American Medical Association. 296 (3): 283–91. PMID 16849661. Unknown parameter
|month=ignored (help); Unknown parameter|coauthors=ignored (help);|access-date=requires|url=(help)
Treatment
Treatment
Medical Therapy | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH



